NCT03474627

Brief Summary

The study aims to investigate the radiological and histomorphometric results of the use of PLGA-coated biphasic calcium phosphate granules in sinus floor elevation, to analyze the underlying molecular processes by immunohistochemical staining, and to evaluate the handling of the biomaterial and the in situ hardening properties. A randomized clinical study is designed to include patients in need of two-stage sinus floor elevation. Patients are assigned to receive either PLGA-coated biphasic calcium phosphate particles (group I) or the equivalent but non-coated particles (group II). CBCT scans are performed before and 6 months after the procedure to assess the bone height gain. At the time of implant placement, bone core biopsies are obtained at the site of implant placement. Histological sections are subjected to histomorphometric and immunohistochemical evaluation of differentiation markers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

March 15, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 22, 2018

Completed
Last Updated

March 22, 2018

Status Verified

March 1, 2018

Enrollment Period

2.1 years

First QC Date

March 15, 2018

Last Update Submit

March 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sinus floor height change

    CBCT scans are performed before the sinus floor elevation and 6 months later before implant placement to measure vertical bone height from the crestal bone to the floor of the maxillary sinus.

    6 months

Secondary Outcomes (3)

  • Area of new mineralized tissue

    6 months

  • Area of non-mineralized tissue

    6 months

  • Area of remaining graft particles

    6 months

Study Arms (2)

Non-coated HA/TCP particles

ACTIVE COMPARATOR

Biphasic hydroxyapatite and beta-tricalcium phosphate bone graft

Device: Non-coated HA/TCP particles

PLGA-coated HA/TCP particles

EXPERIMENTAL

Biphasic hydroxyapatite and beta-tricalcium phosphate bone graft with PLGA coating

Device: PLGA-coated HA/TCP particles

Interventions

Maxillary sinus floor elevation and bone grafting with the use of biphasic hydroxyapatite and beta-tricalcium phosphate bone graft

Non-coated HA/TCP particles

Maxillary sinus floor elevation and bone grafting with the use of biphasic hydroxyapatite and beta-tricalcium phosphate bone graft with PLGA coating

PLGA-coated HA/TCP particles

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Partially edentulous patients.
  • Kennedy class I or II in the upper jaw, from first premolar to second molar.
  • Less than 5 mm of residual crestal bone.
  • Need for the replacement of teeth with dental implants.

You may not qualify if:

  • Sinus pathology (sinusitis, mucocele, cysts).
  • Smokers.
  • Previous long-term (\>3 months) use of drugs known to affect bone metabolism, such as bisphosphonates.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Granada

Granada, 18071, Spain

Location

Universidad de Valencia

Valencia, 46010, Spain

Location

Related Publications (4)

  • Galindo-Moreno P, Hernandez-Cortes P, Mesa F, Carranza N, Juodzbalys G, Aguilar M, O'Valle F. Slow resorption of anorganic bovine bone by osteoclasts in maxillary sinus augmentation. Clin Implant Dent Relat Res. 2013 Dec;15(6):858-66. doi: 10.1111/j.1708-8208.2012.00445.x. Epub 2012 Feb 29.

    PMID: 22376122BACKGROUND
  • Ortega-Oller I, Del Castillo-Santaella T, Padial-Molina M, Galindo-Moreno P, Jodar-Reyes AB, Peula-Garcia JM. Dual delivery nanosystem for biomolecules. Formulation, characterization, and in vitro release. Colloids Surf B Biointerfaces. 2017 Nov 1;159:586-595. doi: 10.1016/j.colsurfb.2017.08.027. Epub 2017 Aug 24.

    PMID: 28854415BACKGROUND
  • Galindo-Moreno P, Avila G, Fernandez-Barbero JE, Aguilar M, Sanchez-Fernandez E, Cutando A, Wang HL. Evaluation of sinus floor elevation using a composite bone graft mixture. Clin Oral Implants Res. 2007 Jun;18(3):376-82. doi: 10.1111/j.1600-0501.2007.01337.x. Epub 2007 Mar 12.

    PMID: 17355356BACKGROUND
  • Galindo-Moreno P, de Buitrago JG, Padial-Molina M, Fernandez-Barbero JE, Ata-Ali J, O Valle F. Histopathological comparison of healing after maxillary sinus augmentation using xenograft mixed with autogenous bone versus allograft mixed with autogenous bone. Clin Oral Implants Res. 2018 Feb;29(2):192-201. doi: 10.1111/clr.13098. Epub 2017 Oct 26.

    PMID: 29071736BACKGROUND

Study Officials

  • Antonio J Flichy-Fernandez, DDS

    University of Valencia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Oral Surgery and Implant Dentistry

Study Record Dates

First Submitted

March 15, 2018

First Posted

March 22, 2018

Study Start

February 1, 2012

Primary Completion

March 1, 2014

Study Completion

March 1, 2017

Last Updated

March 22, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations